U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07105514) titled 'Indole-3-PROpionic Acid Clinical Trials - a Pilot Study Part 2' on July 17.

Brief Summary: The goal of this trial is to investigate the biological effects of oral supplementation with indole-3-propionic acid (IPA) taken twice daily in healthy adults. The main scientific questions are:

* Does supplementation with IPA increase the abundance of regulatory T cells in the blood? Regulatory T cells are believed to play an important role in preventing autoimmune diseases.

* Does supplementation with IPA increase the concentration of brain-derived neurotrophic factor (BDNF) in the blood? BDNF is believed to play an important role in mainta...